Efficacy, Safety and Responder Subanalysis of Lenalidomide in Heavily Pretreated, Relapsed/Refractory Patients With Mantle Cell Lymphoma Post-Bortezomib: Phase II MCL-001 “EMERGE” Study
Titel:
Efficacy, Safety and Responder Subanalysis of Lenalidomide in Heavily Pretreated, Relapsed/Refractory Patients With Mantle Cell Lymphoma Post-Bortezomib: Phase II MCL-001 “EMERGE” Study
Auteur:
Goy, Andre Williams, Michael E. Besisik, Sevgi Kalayoglu Drach, Johannes Ramchandren, Radhakrishnan Zhang, Lei Cicero, Sherri Fu, Tommy Witzig, Thomas